PEDIATRIK ITPDA TROMBOTSIT VA GEMOSTAZ PARAMETRLARINI BAHOLASH

To’ymurodova Zarinabonu Elmurod qizi

Buxoro davlat tibbiyot instituti gematologiya va transfuziologiya kafedrasi 1-kurs magistranti

Keywords: Idiopatik trombositopenik purpura, ITP, pediatrik, trombotsitlar soni, gemostaz parametrlar, diagnostika, qon ketish xavfi.

---

Abstract

Ushbu maqolada pediatrik idiopatik trombositopenik purpura (ITP) bemorlarida trombotsitlar soni va gemostaz parametrlarining diagnostik va klinik ahamiyati o‘rganilgan. Tadqiqot natijalari shuni ko‘rsatdiki, trombotsit disfunksiyasi va gemostaz tizimidagi buzilishlarni birgalikda baholash bolalarda qon ketish xavfini aniqlash, kasallik og‘irligini baholash va individual davolash strategiyasini tanlashda muhim diagnostik vosita sifatida ishlatiladi. Gemostaz ko‘rsatkichlarini monitoring qilish terapevtik qarorlarni optimallashtirishga, davolash samaradorligini baholashga va bolalarda ITP bilan bog‘liq asoratlarni oldini olishga yordam beradi.

---

References

1. Neunert C. E., Lim W., Crowther M., et al. The American Society of Hematology

2019 guidelines for immune thrombocytopenia. Blood, 2019;133(5): 540–558.

2. Provan D., Arnold D. M., Bussel J. B., et al. Updated international consensus

report on the investigation and management of primary immune

thrombocytopenia. Blood Advances, 2019;3(22): 3780–3817.

3. Imbach P., Barandun S., D’Apuzzo V., et al. High-dose intravenous

gammaglobulin for idiopathic thrombocytopenic purpura in childhood. The

Lancet, 1981;1: 1228–1231.

4. Bussel J., Kuter D., George J. Immune thrombocytopenia: diagnosis and

management guidelines. Hematology/Oncology Clinics of North America,

2004;18(6): 1267–1286.

5. Blanchette V., Key N., Lakshmanan A., et al. Guidelines for the management of

childhood ITP. Pediatric Blood & Cancer, 2003;41(3): 145–153.

6. Rodeghiero F., Stasi R., Gernsheimer T., et al. Standardization of terminology,

definitions and outcome criteria in immune thrombocytopenic purpura of adults

and children: report from an international working group. Blood, 2009;113(11):

2386–2393.

7. Cines D. B., Blanchette V. S. Immune thrombocytopenic purpura. New England

Journal of Medicine, 2002;346: 995–1008.

8. Neunert C., Terrell D. R., Arnold D. M., et al. American Society of Hematology

2011 evidence-based practice guideline for immune thrombocytopenia. Blood,

2011;117(16): 4190–4207.

9. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura.

Seminars in Hematology, 2000;37: 5–9.

10.Bussel J. B., Saleh M. N. Thrombopoietin receptor agonists in immune

thrombocytopenia: a review. British Journal of Haematology, 2008;143: 336–

348.